Experimental Study of Hypolipidemic Effect of Manjal Noiku Kudineer

Hyperlipidemia, is a major stake for the development of serious diseases like atherosclerosis, Coronary Artery Diseases, Stroke. Siddha system of Medicine with the numerous combination of medicines has Manjal Noiku Kudineer(MNK), a Siddha poly herbal formulation indicated for Manjal Noi. This study deals with the Hypolipidemic activity of Manjal Noiku Kudineer on atherogenic diet induced hyperlipidemia in experimental Wistar Albino Rats

Place of Study: The study was conducted at Arulmigu Kalasalingam College of Pharmacy, Virudhunagar.

Methodology: The study protocol for MNK was reviewed and approved by Institutional Animal Ethics Committee (IAEC), Arulmigu Kalasalingam College of Pharmacy, Virudhunagar, with the IAEC number AKCP/IAEC/10/24-25. The experimental hyperlipidemic diet consists of well-pulverized 400 mg/kg cholesterol, 50 mg/kg cholic acid, and coconut oil. All groups other than the control group were fed the prepared atherogenic meal in lieu of the regular pellet diet. Group I served as normal control, Group II represented hyperlipidemic control rats given an atherogenic diet, Group III and IV represented test groups given MNK 200 mg/kg and MNK 400 mg/kg, respectively, and Group V represented standard-administered atorvastatin (10 mg/kg/day). All groups were compared, observations were noted and the observations were statistically evaluated.

Results: The study shows the results of reduction in body weight, blood lipid profile, liver lipid profile of hyperlipidemic rats on treating with the study medicine, which possess hypolipidemic activity. Histopathologic images of rat liver also shown normal parenchyma and parenchyma with minimal necrosis and minimal inflammatory changes on treating with the study medicine MNK.

Conclusion: The results stands as a support for MNK hypolipidemic activity, which in turn can be used as a antihyperlipidemic therapeutic agent from the Siddha System of Medicine.